Clinical Trial Update: Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria Transmission [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated artemether-lumefantrine alone and in combination with ivermectin to reduce post-treatment malaria transmission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Artemether-lumefantrine (artemether and lumefantrine)
• IVERMECTIN (Ivermectin)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED